跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 231 条关于
“OT-S00X”
全部
231
临床试验
129
药物
82
机构
2
资讯
18
10个月前
Onward Therapeutics Secures Worldwide License for Novel Onco-Metabolism Program OT-S00X
去年
Oncotelic Therapeutics Completes Phase 1 Trial of OT-101/IL-2 Combination for Advanced Solid Tumors
10个月前
Oncotelic's Pipeline Receives $1.7 Billion Valuation as OT-101 Advances to Phase 3 Trials
7个月前
Oncotelic Therapeutics Expands Global Patent Protection for OT-101 TGF-β Antisense Therapy Across CNS and Neurology Applications
去年
Ocumension Therapeutics Completes Enrollment in Phase III Trial of OT-301 for Glaucoma and Ocular Hypertension
12年前
Comparative Evaluation of High-Flow Nasal Cannula and Conventional O2 Therapy in Pediatric Cardiac Surgical Patients
去年
TGFB2 Gene Methylation Identified as Positive Prognostic Biomarker for Pancreatic Cancer
去年
Oncotelic Therapeutics Reports Progress Across Six Late-Stage Drug Programs in Oncology and Rare Diseases
去年
Oncotelic Therapeutics Advances Clinical Pipeline Led by CEO's $4.2B Patent Legacy
去年
CyanVac's Intranasal COVID-19 Vaccine Candidate, CVXGA, Enters Phase 2b Trial
第 1 页,共 2 页
上一页
下一页